Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine in elderly patients undergoing gastrointestinal tumor surgery
ChiCTR2200064076Phase 4Not yet recruiting
- Sponsor
- Changzhi People's Hospital
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of esketamine in gastrointestinal neoplasia (2 arms), sponsored by Changzhi People's Hospital. Primary endpoints: Montreal Cognitive Assessment Scale, IL-1β and 8 more. Planned start Sep 2022; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
gastrointestinal neoplasia
Beyond the preview
Go deeper on ChiCTR2200064076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200064076.